Robert H. Getzenberg, Ph.D.

Executive Associate Dean for Research / Professor, Medicine
(954) 262-1492

Dr. Robert H. Getzenberg joined the Dr. Kiran C. Patel College of Allopathic Medicine in 2018 as Executive Associate Dean for Research / Professor, Medicine. He oversees the college’s research portfolio with a focus on enhancing collaboration, supporting federal grant funding processes, and developing efficiencies to translate findings from the bench to the bedside. 

Dr. Getzenberg has a led a distinguished career as a translational researcher and research executive.  Prior to joining NSU, he was chief scientific officer at Veru Inc. in Miami. In this role, he directed the development of novel therapeutic approaches to urologic diseases, including prostate cancer and BPH.  These projects ranged from early stage development to evaluating agents in clinical trials. He previously served as a therapeutic area lead at GTx Inc. in Memphis, Tenn. Prior to that, he was the director of research for the James Buchanan Brady Urological Institute and the Donald S. Coffey Professor of Urology and professor of pharmacology and molecular sciences at the Johns Hopkins University School of Medicine in Baltimore. He also served as co-director of the Prostate Cancer Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital. 

Dr. Getzenberg received his Doctor of Philosophy degree from the Johns Hopkins University School of Medicine in 1992 under the tutelage of Donald S. Coffey, Ph.D. He then completed a post-doctoral fellowship at the Yale University School of Medicine in New Haven, Conn. After completing his fellowship, Dr. Getzenberg joined the University of Pittsburgh as an assistant professor and later was named the director of urology research and a professor of urology, pathology and pharmacology. At both the Johns Hopkins University and University of Pittsburgh School of Medicines, Dr. Getzenberg served in leadership roles in their respective graduate programs.  He has educated and worked with fellows, residents, and graduate and undergraduate students throughout his career.

Dr. Getzenberg has received many awards and honors, including the University of Pittsburgh chancellor’s Distinguished Research Award, and was recognized among the “40 under 40” by Pittsburgh Magazine.  He has received multiple grants from the National Institutes of Health and other agencies and foundations including the Prostate Cancer Foundation. He has given numerous international lectures related to his work, including the first Donald Gleason Lecture at the University of Minnesota in 2012 and the Weisbach Lecture at the University of Michigan in 2007. He has also served as the keynote speaker at urology and oncology meetings in Japan, China, and throughout Europe. 

Dr. Getzenberg has held and continues to hold many research leadership positions and has authored numerous manuscripts and book chapters in the field. His major research interests focus on developing novel therapeutic approaches with which to personalize the therapeutic pathway for individual patients.